<DOC>
	<DOC>NCT02178293</DOC>
	<brief_summary>A study to in order to verify any differences between the 2 treatment groups in terms of duration of analgesic effects after the first drug intake and time to remission of symptoms and signs of pharyngitis</brief_summary>
	<brief_title>Ketoprofen Lysine Salt as Mouthwash in Acute Phlogosis of the Pharyngeal Cavity Versus Benzidamine Hydrochloride</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Ketoprofen lysine</mesh_term>
	<mesh_term>Benzydamine</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<criteria>Male and female outpatients, aged 18 to 70 years, suffering from acute pharyngitis, pharyngolaryngitis Moderately or severely intense pain in the pharyngeal region (score ≥ 70 mm) from the "visual analogue scale" (VAS) At least 1 of the 2 inflammation signs (edema and hyperemia) to be moderately or severely intense (score ≥ 2) from the scoring scale from 0 to 3 Release of written informed consent by the patient Patients suffering from a microbial infection requiring specific antimicrobial treatment Patients who have taken the trial drugs during the week before enrolment Patients who have taken corticosteroids or antibiotics during the week before enrolment Ascertained or suspected hypersensitivity to trial drugs or to chemically correlated drugs or to other nonsteroidal antiinflammatory drugs or to mouthwashes in general Patients who are unable to properly fill in the diary every day as provided for by the protocol Ascertained or presumed pregnant or lactating women Inclusion in any other clinical trial during the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>